Circadian Variation of Migraine Attack Onset: A Review of Clinical Studies by Baksa, Dániel et al.
Review Article
Circadian Variation of Migraine Attack Onset:
A Review of Clinical Studies
Daniel Baksa ,1,2 Kinga Gecse,1,2 Sahel Kumar,2,3 Zsuzsanna Toth,1,2 Zsofia Gal,3,4
Xenia Gonda,3,5,6 and Gabriella Juhasz 1,2,3,7
1 SE-NAP2 Genetic Brain Imaging Migraine Research Group, Hungarian Brain Research Program, Semmelweis University,
Budapest, Hungary
2Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary
3MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University,
Budapest, Hungary
4Department of Physiology and Neurobiology, Institute of Biology, Faculty of Science, Eotvos Lorand University, Budapest, Hungary
5NAP-2-SE New Antidepressant Target Research Group, Hungarian Brain Research Program, Semmelweis University,
Budapest, Hungary
6Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary
7Neuroscience and Psychiatry Unit, The University of Manchester and Manchester Academic Health Sciences Centre, Manchester, UK
Correspondence should be addressed to Gabriella Juhasz; juhasz.gabriella@pharma.semmelweis-univ.hu
Received 29 May 2019; Accepted 21 July 2019; Published 25 August 2019
Academic Editor: Kazuhiko Kotani
Copyright © 2019 Daniel Baksa et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Several studies suggested that migraine attack onset shows a circadian variation; however, there has not been an overview
and synthesis of these findings. A PubMed search with keywords “migraine” AND “circadian” resulted in ten studies directly
investigating this topic. Results of these studies mostly show that migraine attacks follow a monophasic 24-hour cyclic pattern
with an early morning or late night peak while other studies reported an afternoon peak and also a biphasic 24-hour cycle of
attacks. The identified studies showed methodological variation including sample size, inclusion of medication use, comorbidities,
and night or shift workers which could have contributed to the contradictory results. Several theories emerged explaining the
diurnal distribution of migraine attacks suggesting roles for different phenomena including a morning rise in cortisol levels, a
possible hypothalamic dysfunction, a circadian variation of migraine triggers, sleep stages, and a potentially different setting of the
circadian pacemaker amongmigraineurs. At the moment,most studies show an early morning or late night peak of migraine attack
onset, but a significant amount of studies reveals contradictory results. Further studies should investigate the arising hypotheses to
improve our understanding of the complex mechanism behind the circadian variation of migraine attacks that can shed light on
new targets for migraine therapy.
1. Introduction
Migraine is a serious and debilitating condition with several
comorbidities and a global age-standardized prevalence of
14.4% according to a recent systematic analysis [1]. The dis-
ease predominantly affects females with a female-male ratio
of 3:1 [2]. The most prevalent form is migraine without aura,
which is characterized by usually unilateral, moderate, or
severe pulsating headache with nausea, vomiting, and photo-
and phonophobia. Approximately one-third of migraineurs
also show transient neurological deficits associated with
their migraine attacks, collectively termed migraine aura
(for example, sensory, retinal, or motor symptoms) [2].
While this high prevalence and the high burden associated
with migraine motivate research for underlying pathomech-
anisms, there is still no clear explanation of when and why
a migraine attack will occur. Both clinicians and patients
have noted the diurnal variation of migraine attack onset
and several terms have been used to describe the periodicity
of migraine attacks including cyclical migraine, weekend, or
nocturnal migraine, suggesting that migraine attacks do not
occur randomly but show distinct temporal patterns [3]. A
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better understanding of the circadian variation of migraine
attack onset could provide relevant information for migraine
prevention and intervention. For example, a pulsatile press
coated drug delivery of sumatriptan succinate for bedtime
administration was created to ensure early morning release
to prevent migraine attacks after sleep [4].
However, less than a dozen studies examined directly the
circadian variation ofmigraine attack onset, and the synthesis
of these findings has not taken place yet. Therefore, in our
review we aimed to collect, organize, and synthesize the
results of studies regarding the 24-hour variation in migraine
attack onset.We also assemble the suggested theories explain-
ing these findings.
2. Methods
A PubMed search was performed with keywords ”migraine”
AND ”circadian” in Title/Abstract field to identify studies on
the daily distribution of migraine attacks. The search was
limited to publications in English and published before the
end of August 2018.
After inspecting the retrieved abstracts we selected rele-
vant papers reporting on the 24-hour distribution ofmigraine
attacks and collated research data from those directly inves-
tigating the circadian variation of migraine attack onset.
3. Results
3.1. Literature Search Results. Our search identified 90
abstracts. After inspecting the abstracts, we excluded arti-
cles discussing other diseases (not migraine) and/or other
than circadian aspects of migraine—we selected 30 papers
with possibly relevant information on diurnal variation of
migraine attack onset. At this stage, we also kept reviews with
possible data of original studies. At the final step, after reading
the selected papers, 10 studies were identified that directly
investigated the circadian variation of migraine attack onset
providing new data (for details see Figure 1). In the following
we used data from these articles.
3.2. Circadian Variation Pattern of Migraine Attack Onset
Reported in the Identified Studies. Results of the selected 10
publications are summarized in Table 1. Five studies clearly
showed a monophasic 24-hour cyclic pattern of migraine
attacks with an early morning or late night peak [5–9], while
one study reported one early afternoon peak [3].
The remaining four studies revealed a biphasic 24-hour
cycle of attacks. Three of them showed one peak in the
morning hours (with a timing similar to that in the majority
of the papers that found only one peak), but identified
another peaks set at different times: (1) late at night [10], (2)
in the afternoon (in a pediatric sample) [11], and (3) just after
noon in cases of insomnia-related migraine attacks [12]. The
latter study interestingly also showed that attacks unrelated
to insomnia peaked only once just after noon [12], which is
similar to a finding reported previously by the same research
group although in a highly overlapping sample [3]. Another
recent article described a peak in the forenoon and another
one in the evening, but the authors highlighted that most
Records of PubMed search
n=90
Records excluded
(not relevant)
n=60
Records after
reading the selected 
abstracts
n=30 Records excluded
(not directly
investigated 24-hour
distribution of
migraine attacks)
n=20
Papers included in
review after reading
the selected articles
n=10
Figure 1: Flowchart of study selection strategy performed after
PubMed search for studies directly investigating the circadian
variation of migraine attack onset.
participants did not report a constant daily distribution of
their migraine attacks [13].
3.3. Details of the Studies on Circadian Variation of Migraine
Attack Onset. Relevant characteristics of the identified stud-
ies are shown in Table 1. The majority of studies used a
prospective longitudinal design including some with one-
year follow-up period, although with much smaller sample
sizes compared to those used in one of the two retrospective
studies [6] and in a cross-sectional study [10].
The samples mostly consisted of females in their late
thirties or forties, although, surprisingly, some studies lack
these crucial basic information [7, 9]. One study involved
patients from a pediatric population [11].The effect of gender
was adjusted in two studies: Soriani et al. [11] did not find
difference between gender groups in a pediatric sample, and
van Oosterhout et al. [10] also could not detect any effect
of gender. The effect of age was corrected also only in two
recent studies: van Oosterhout et al. [10] showed that earlier
migraine attack onset (12PM-6AM) was related to higher
age, and de Tommaso & Delussi [13] similarly found that
migraineurs with prevalent night attack onset (12PM-5AM)
were older than the other headache onset groups, except
the morning onset group (6AM-12AM). Participants were in
most cases migraine patients both with and without aura,
but a number of participants belonging to these subgroups
are not specified in many articles. Only one study included
a sample of chronic migraineurs [13]. For diagnostic criteria
every study used a version of the International Headache
Society guideline (ICHD) that was available at the time the
study was carried out. All the studies used a paper headache
diary, except two: Park et al. [8] worked with a smartphone
BioMed Research International 3
Ta
bl
e
1:
D
et
ai
ls
an
d
re
su
lts
of
th
es
tu
di
es
on
ci
rc
ad
ia
n
va
ria
tio
n
of
m
ig
ra
in
ea
tta
ck
on
se
t.
St
ud
y
D
es
ig
n
Ti
m
e-
sp
an
Sa
m
pl
e
A
ge
(y
ea
rs
)
[a
dj
us
tm
en
t
fo
re
ffe
ct
:∗
]
Fe
m
al
e
[a
dj
us
t-
m
en
tf
or
eff
ec
t:
∗
]
M
ig
ra
in
e
ty
pe
(s
am
pl
e
siz
ei
f
av
ai
la
bl
e)
M
ed
ic
at
io
n
C
om
or
bi
d
fa
ct
or
s
N
ig
ht
wo
rk
/s
hi
ft
wo
rk
Ci
rc
ad
ia
n
va
ria
tio
n
of
at
ta
ck
on
se
t
(p
ea
k)
St
ud
ies
sh
ow
in
ga
m
on
op
ha
sic
24
-h
ou
rc
yc
lic
m
an
ne
ro
fm
igr
ai
ne
at
ta
ck
s
So
lo
m
on
(19
92
)
[9
]
pr
os
pe
ct
iv
e
20
we
ek
s
15
pa
tie
nt
s
(U
SA
)
no
da
ta
no
da
ta
M
O
,M
A
N
SA
ID
or
pl
ac
eb
o
us
ed
(b
et
a-
bl
oc
ke
rs
ex
clu
de
d)
he
al
th
y
(e
xc
ep
t
m
ig
ra
in
e)
no
da
ta
6 A
M
-1
2 A
M
Fo
x
&
D
av
is
(19
98
)[
6]
re
tro
sp
ec
tiv
e
la
st
3
ye
ar
s
16
98
pa
tie
nt
s
(U
SA
)
fro
m
18
to
60
+
89
%
M
O
,M
A
us
eo
fo
ra
lc
on
tr
ac
ep
tiv
es
in
clu
de
d
no
da
ta
in
clu
de
d
4 A
M
-9
A
M
Fo
x
(2
00
5)
[5
]
lit
er
at
ur
ed
at
a
an
al
ys
is
-
16
98
pa
tie
nt
s
(U
SA
)
fro
m
18
(m
ed
ia
n:
34
)
∼
4:
1
M
O
,M
A
ex
clu
de
d
w.
or
al
co
nt
ra
ce
pt
iv
es
no
da
ta
no
ti
nc
lu
de
d
1 A
M
-6
A
M
G
or
i,
et
al
.
(2
00
5)
[7
]
re
tro
sp
ec
tiv
e
la
st
3
m
on
th
s
10
0
pa
tie
nt
s
(It
al
y)
pa
tie
nt
s
(2
3-
50
),
m
ea
n:
38
.6
;
co
nt
ro
l
(2
3-
60
),
m
ea
n:
37
.1
no
da
ta
M
O
no
da
ta
de
pr
es
sio
n
an
d
an
xi
et
y
sy
m
pt
om
s;
sle
ep
qu
al
ity
no
da
ta
3 A
M
-7
A
M
A
lst
ad
ha
ug
,e
t
al
.(
20
08
)[
3]
pr
os
pe
ct
iv
e
12
m
on
th
s
84
pa
tie
nt
s
(a
rc
tic
)
m
ea
n
∼
35
10
0%
M
O
(3
4)
,
M
O
+M
A
(5
0)
us
eo
fo
ra
lc
on
tr
ac
ep
tiv
es
,
be
ta
-b
lo
ck
er
si
nc
lu
de
d
he
al
th
y
(e
xc
ep
t
m
ig
ra
in
e)
;
in
so
m
ni
a
in
clu
de
d
at
1.
40
PM
Pa
rk
,e
ta
l.
(2
01
8)
[8
]
pr
os
pe
ct
iv
e
90
da
ys
82
pa
tie
nt
s
(K
or
ea
)
m
ea
n
37
.4
84
.1%
M
O
(8
1)
,M
A
(1
)
us
eo
fa
cu
te
&
pr
ev
en
tiv
e
m
ed
ic
at
io
n
al
lo
we
d
no
n-
m
ig
ra
in
e
ty
pe
he
ad
ac
he
no
ti
nc
lu
de
d
6 A
M
-1
2 A
M
4 BioMed Research International
Ta
bl
e
1:
C
on
tin
ue
d.
St
ud
y
D
es
ig
n
Ti
m
e-
sp
an
Sa
m
pl
e
A
ge
(y
ea
rs
)
[a
dj
us
tm
en
t
fo
re
ffe
ct
:∗
]
Fe
m
al
e
[a
dj
us
t-
m
en
tf
or
eff
ec
t:
∗
]
M
ig
ra
in
e
ty
pe
(s
am
pl
e
siz
ei
f
av
ai
la
bl
e)
M
ed
ic
at
io
n
C
om
or
bi
d
fa
ct
or
s
N
ig
ht
wo
rk
/s
hi
ft
wo
rk
Ci
rc
ad
ia
n
va
ria
tio
n
of
at
ta
ck
on
se
t
(p
ea
k)
St
ud
ies
sh
ow
in
ga
bi
ph
as
ic
24
-h
ou
rc
yc
lic
m
an
ne
ro
fm
igr
ai
ne
at
ta
ck
s
So
ria
ni
,e
ta
l.
(2
00
6)
[1
1]
pr
os
pe
ct
iv
e
12
m
on
th
s
115
pa
tie
nt
s
(p
ed
ia
tr
ic
)
(It
al
y)
5-
18
yr
s
(m
ed
ia
n:
∼
10
)
47
%
[∗
]
M
O
ex
clu
de
d
if
ta
ki
ng
pr
op
hy
la
ct
ic
m
ed
ic
at
io
n
no
da
ta
-
m
ai
n
pe
ak
at
4:
48
PM
,
se
co
nd
ar
y
pe
ak
at
6:
35
A
M
A
lst
ad
ha
ug
,e
t
al
.(
20
07
)[
12
]
pr
os
pe
ct
iv
e
12
m
on
th
s
68
pa
tie
nt
s
(a
rc
tic
)
m
ea
n
35
.5
10
0%
M
O
,M
A
(in
so
m
ni
a-
re
la
te
d
(2
9%
)
&
no
tr
el
at
ed
at
ta
ck
s)
ex
clu
de
d
if
ta
ke
n
be
ta
-b
lo
ck
er
s
po
ss
ib
le
ch
ro
ni
c
in
so
m
ni
a;
sle
ep
qu
al
ity
on
th
e
ni
gh
tp
rio
rt
o
or
th
en
ig
ht
of
th
e
at
ta
ck
no
ti
nc
lu
de
d
in
so
m
ni
a
re
la
te
d:
pe
ak
ea
rly
in
th
e
m
or
ni
ng
(∼
8 A
M
)&
ju
st
aft
er
no
on
/n
ot
re
la
te
d:
pe
ak
ju
st
aft
er
no
on
va
n
O
os
te
rh
ou
t,
et
al
.(
20
18
)[
10
]
cr
os
s-
se
ct
io
na
l
-
23
89
pa
tie
nt
s,
18
9
co
nt
ro
ls
(D
ut
ch
)
m
ea
n
45
.2
[∗
]
83
.4
%
[∗
]
M
O
,M
A
us
eo
fs
le
ep
m
ed
ic
at
io
n
(n
o
da
ta
on
m
ig
ra
in
em
ed
ic
at
io
n)
de
pr
es
sio
n
an
d
an
xi
et
y
sy
m
pt
om
s,
lif
et
im
e
de
pr
es
sio
n;
sle
ep
qu
al
ity
in
clu
de
d
pe
ak
s:
fro
m
m
id
ni
gh
tt
o
6 A
M
(3
4.
5%
)&
fro
m
6 A
M
to
no
on
(3
1.7
%
)
de
To
m
m
as
o
&
D
elu
ss
i(
20
18
)
[1
3]
pr
os
pe
ct
iv
e
3m
on
th
s
78
6
ca
se
s
(It
al
y)
m
ea
ns
:M
O
–
37
.4
;
M
O
+M
A
–
34
.2
;C
M
–
42
.5
[∗
]
∼
80
%
M
O
(5
38
),
M
O
+M
A
(5
2)
,C
M
(19
6)
ex
clu
sio
n:
us
eo
fc
en
tr
al
ne
rv
ou
s
sy
ste
m
-a
ct
iv
ed
ru
gs
or
pr
ev
en
tiv
e
tre
at
m
en
tf
or
pr
im
ar
y
he
ad
ac
he
he
al
th
y
(e
xc
ep
t
m
ig
ra
in
e)
;
de
pr
es
sio
n
an
d
an
xi
et
y
sy
m
pt
om
s;
sle
ep
fe
at
ur
es
;q
ua
lit
y
of
lif
e
no
da
ta
tw
o
pe
ak
s:
at
10
A
M
&
at
10
PM
(b
ut
m
os
tp
at
ie
nt
s
di
d
no
tr
ep
or
t
ac
on
sta
nt
ci
rc
ad
ia
n
rh
yt
hm
of
th
ei
ra
tta
ck
s)
Ta
bl
e1
sh
ow
st
he
re
su
lts
an
d
ot
he
ri
m
po
rt
an
td
et
ai
ls
of
th
e
se
le
ct
ed
stu
di
es
on
ci
rc
ad
ia
n
va
ria
tio
n
of
m
ig
ra
in
e
at
ta
ck
on
se
t.
Ab
br
ev
ia
tio
ns
.C
M
:c
hr
on
ic
m
ig
ra
in
e;
M
A
:m
ig
ra
in
e
w
ith
au
ra
;M
O
:m
ig
ra
in
e
w
ith
ou
t
au
ra
;N
SA
ID
:n
on
ste
ro
id
al
an
ti-
in
fla
m
m
at
or
y
dr
ug
;∗
:a
dj
us
tm
en
tf
or
eff
ec
t.
BioMed Research International 5
headache diary, and vanOosterhout et al. [10] proceededwith
a digital questionnaire.
There is a significant variation between studies regarding
medication use in participants. Half of the studies measured
sleep quality and/or insomnia [3, 7, 10, 12, 13]. Depression
and anxiety symptoms were controlled in only three studies
[7, 10, 13]. One study included data on nonmigraine headache
besides migraine [8]. Three studies did not provide any
information on possible comorbidities [5, 6, 11].The inclusion
of night or shift workers also diverges considerably and three
papers [7, 9, 13] even lack this data.
4. Discussion
The majority of studies on circadian variation of migraine
attack onset showed an early morning or late night peak,
while other studies reported an afternoon peak or revealed
a biphasic cycle of attacks. Multiple theories have been
proposed to explain these results.
4.1. Theories Explaining the Circadian Variation of Migraine
Attack Onset. The author of the first related study [9]
suggested that there is a parallel pattern between migraine,
nonfatal myocardial infarction, and sudden cardiac death, all
showing a similar circadian rhythm with an early morning
peak and sharing other similarities including changes in
vasomotor tone and platelet hyperaggregability. Indeed, a
higher risk of myocardial infarction has been associated with
migraine in a recent meta-analysis [14]. Solomon [9] also
noted that platelet hyperaggregability could result in sero-
tonin release potentially contributing to vasospasm which
may trigger migraine attacks. Serotonergic neurons can
influence the trigeminal system, which has a well-known role
in migraine pathophysiology [15], shows increased activity
during sleep, and can thus precipitate headaches [16].
Others [6] highlighted that plasma cortisol and adreno-
corticotropic hormone (ACTH) levels also show a synchro-
nized zenith in the morning hours. One study [17] reported
that migraine patients (compared to headache-free controls)
showed higher variation of cortisol level at multiple time
periods. Among the investigated migraineurs, subgroups
were identifiedwith the following parameters: (1) consistently
higher cortisol levels; (2) aberrant pattern of cortisol levels
(for example, a rise in cortisol level when all controls and
most patients showed a fall); (3) lower cortisol levels at
multiple time periods; (4) a similar pattern to controls.
Interestingly, the relationship between cortisol level and
headache pain was not consistent: only a tendency was found
for high cortisol level during pain experience, but severe pain
was also reported at normal and low cortisol levels in many
cases (and high cortisol level was also addressed during the
absence of pain). These results suggest that cortisol, with a
peak in the early morning hours, might contribute to some
migraine attacks in the morning, but only among some
migraineurs. Therefore, it is not surprising that according
to a recent review [18] the majority of the studies working
with different subgroups of migraineurs and measuring
migraine attacks occurring at different times reported that
morning cortisol levels did not differ between migraineurs
and controls. An interesting prospective longitudinal study
applying various stress measures (including morning and
evening saliva cortisol) over four days prior to a spontaneous
migraine attack onset could not identify a temporal relation-
ship between cortisol changes (or changes in any other stress-
related measures) and migraine attack onset [19].
Many other hormones related tomigraine alsomight have
a role in circadian variation of migraine attack onset. For
example, a study found elevated levels of follicle-stimulating
hormone in migraineurs with and without aura (in both
sexes) which could be attributed to disturbances in sleep-
wake cycle, but no other significant differences were detected
in levels of luteinizing hormone, cortisol, and prolactin
[20]. Another study with chronic migraine (CM) patients
(compared to healthy controls) showed an abnormal pattern
of hormones secreted in hypothalamus during the night: a
phase-delay in melatonin peak and lower melatonin levels
among CM patients with insomnia, suggesting a possible
chronobiological dysfunction; a decreased prolactin peak,
contributing to a possible hyperdopaminergic state; a higher
cortisol concentration; but no difference in growth hormone
secretion [21]. Melatonin as a known marker of the circadian
clock may be particularly important in understanding the
diurnal variation of migraine attack onset. The related studies
mostly show lower melatonin levels among migraineurs ver-
sus controls [22], but future studies are needed to understand
the exact role of melatonin in migraine pathophysiology and
its potential effect on attack onset.
Authors of a recent study [8] collected results suggesting
that early morning migraine attacks are associated with
more severe symptoms (compared to attacks occurring at
other times), and perceived pain intensity also shows its
maximum early in the morning. They emphasized the role
of a possible hypothalamic dysfunction in migraine which
may contribute to the circadian variation of migraine attack
onset through the hypothalamic involvement in nociception
and circadian periodicity.Themain circadian pacemaker, the
suprachiasmatic nucleus, is located in the hypothalamus [23].
A recent study utilizing high-resolution brainstem imaging
with trigeminal nociceptive stimulation showed increased
hypothalamic activation in chronic migraineurs compared to
headache-free controls, and also among chronic migraineurs
compared to episodicmigraineurs when participants suffered
headache during scanning [24]. This study also revealed
higher hypothalamic activation in headache state (among
both migraineur types) compared to headache-free state
and healthy controls. These results suggest multiple roles
for the hypothalamus in migraine: (1) in the initiation of
attacks; (2) in acute pain state; and possibly (3) in migraine
chronification.
Another theory was proposed by Park et al. [8] who
suggested that different trigger factors of migraine occur at
different circadian periods, and among them exposure to
excessive sleep and sleep deprivation appear most frequently
in the morning. However, Alstadhaug et al. [12] reported in
an arctic population with significant variations in natural
light that insomnia-related attacks peaked in the morning
and also just after noon, while attacks not related to insomnia
peaked just after noon. Nevertheless, Park et al. [8] notably
6 BioMed Research International
concluded that circadian variation of migraine attack onset
may be a result of interactions between migraine triggers and
the innate circadian periodicity. A social nature of migraine
attack onset has been also suggested by Alstadhaug et al.
[3] suggesting that peak onset in the afternoon might be
connected to work-related stress in comparison to morning
migraine which might be induced by lack of restorative sleep.
Similarly, school activities during the daymight contribute to
an attack onset peak in the afternoon among children [11].
A temporal relationship between migraine and sleep
stages has also been suggested [7]. An EEG study [16] found
thatmigraineurs hadminimal sleep disturbancewith reduced
REM sleep and REM latency. The authors suggested that this
connection may be based on shared aminergic mechanisms,
for example, through decreased serotonin levels found in
both REM sleep [25] and migraine attack [26]. A recent
review [27] reported data about the decreased amount of
slow wave sleep and a possible involvement of REM sleep
in migraine suggesting a probable brainstem dysfunction
in networks involved in switching between sleep stages.
According to this review studies also show the following sleep
characteristics of the night before migraine attacks occur
early in the morning or late at night: increased awakenings,
decreased amount of slow wave sleep, and insomnia.
A possibly different setting of the endogenous circadian
pacemaker in migraineurs has been suggested by van Oost-
erhout et al. [10]. Self-report questionnaire data showed that
migraineurs in comparison to headache-free control subjects
were less flexible in adapting to circadian rhythm changes
and more prone to show an early or late chronotype, and
early morning attacks were related to early chronotype. This
hypothesis may be supported by the result showing that
migraines with or without aura were connected to amutation
in the casein kinase I훿 gene (CKI훿) (with phosphorylating
effect on the Per2 circadian protein) in two families with
advanced sleep phase syndrome [28].
4.2. Methodological Differences between Studies on Circa-
dian Variation of Migraine Attack Onset. We also need
to highlight that the revealed methodological differences
may have significantly contributed to the varying results of
studies on the diurnal distribution of migraine attacks. As a
favourable tendency, most studies used a prospective longi-
tudinal design; however, in most cases this method correlates
with a significant reduction of sample size. A recent study
[13] represents a good example towards a possibly preferable
approach: the researchers employed a prospective design for
a shorter period of time (3 months) with a sample consisting
of nearly 800 patients (a much higher number compared
to other prospective studies). Although, the disadvantage
of this strategy is a shorter follow-up time which might
bias the results, because migraine attacks may also show
seasonal variation. In arctic populations higher frequency of
migraine attacks were found during the bright arctic summer
(mostly among migraineurs with aura) which is probably
connected to the prolonged light exposure that might trigger
migraine [29–31]. A study in Italy identified a peak in January
and the lowest attack incidence in August [32]. Hospital
admissions for migraine have also been detected to show
seasonal variation. A study reviewing a 20-year period in aUS
hospital found that admission of female migraineurs peaks
in spring (in comparison to males) [33]. Studies in pediatric
headache patients (including migraineurs) showed a higher
admission frequency in autumn possibly associated with the
beginning of the school year representing a potential stress
factor for children with headache [34, 35].These data indicate
the importance of considering the possibility of seasonal
variation in migraine attacks in case of a research period
spanning less than a year. The climate of the area where
the research takes place can also be relevant in this regard:
studies performed in different climates and/or with varying
investigation periods can produce contrasting results.
Another important aspect is the exact diagnosis of
migraine patients. Most of the reviewed studies included
samples of migraine patients with and without aura, but
their actual numbers (and other details) were not always
provided. When such subsample sizes are available, there are
large differences in the number of patients in these migraine
categories [8, 13]. Therefore results of these studies may
not be generalizable among migraineurs with and without
aura. Others also highlight that the selected population
type (headache center patients versus general population)
can also contribute to the divergence between results [13].
Migraineurs represent a heterogenous population, so the use
of different subgroups and/or attack types like insomnia-
related and -nonrelated attacks such as in the paper of
Alstadhaug et al. [12] could also be beneficial: it can help
identify specific mechanisms that occur only in a certain
migraine subsample or attack type. Although, this approach
also weakens the comparability of results between studies
employing differently defined migraine subcategories.
Use of allowed medications is a crucial factor in the
reviewed studies. For example beta-blockers might affect the
rhythm of migraine attack onset [9]. The blockage of 훽
1
-
receptors is responsible for sleep disturbances possibly caused
by reduced nocturnal melatonin release [36]. Concerning
sleep medication, short-acting benzodiazepines may increase
the risk of attacks in a dose-dependent way [37]; meanwhile
Z-drug eszopiclone has no influence on migraine [38].
Contraceptives can also contribute to a different setting of
attacks, for example, through changes in hormone level
fluctuations. The drop in estrogen level is a trigger for women
suffering from menstrual migraine. In that case, hormonal
treatment could be preventive [39]. However, oral contra-
ceptives can modulate some circadian rhythm parameters
(e.g., blood pressure, heart rate, skin blood flow), although
without a significant effect on the circadian clock itself
[40]. Nonsteroidal anti-inflammatory drugs (NSAIDs) like
naproxen show no significant changes in circadian patterns
of ACTH and cortisol in healthy volunteers [41]. However, it
was shown [42] that the effect of other NSAIDs on ACTH
and cortisol levels depends on treatment duration. After a
singular intake of indomethacin or acetylsalicylic acid (ASA),
no changes were detected, while after a 4-day treatment,
both medications resulted in changes in stress hormone level.
In insulin induced hypoglycemia stress test, indomethacin
intake resulted in increased ACTH and decreased cortisol
levels, while in case of ASA administration, ACTH levels
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decreased and cortisol levels remained unaltered. These
examples illustrate the need to control for medication use in
studies of circadian variation of migraine attack onset.
Migraine has several comorbidities including ones con-
nected to circadian dysregulation, such as asthma, insomnia
[23], major depressive disorder, and bipolar disorder [43].
Comorbid illnesses can influence migraine symptoms. For
example, migraineurs with comorbid psychiatric diseases
have higher attack frequency compared to migraineurs with-
out psychiatric comorbidities [44]. These data highlight the
need to control for comorbidities in studies on circadian
variation of migraine attack onset. However, only a small
amount of the reviewed studies employed data on comorbidi-
ties, mostly on sleep-related ones and anxiety and depression
symptoms in a few cases. Environmental factors also have
a known role in migraine, including stress [45, 46] which
has also been associated with circadian rhythms through
an interaction between the hypothalamic-pituitary-adrenal
axis and the autonomic nervous system, both involved in
stress regulation and provided with circadian inputs [47].
Therefore, it would be beneficial to control for environ-
mental factors in studies of circadian variation of migraine
attacks.
Night or shift work can result in a circadian disruption
with a potential carcinogenic effect [48]. Sleep disturbances
are known triggers of migraine [49], and a study from
Denmark showed a higher prevalence of treatment-seeking
migraine patients among evening workers [50]. These data
suggest that shift workers should be investigated separately
from (or in comparison with) nonshift workers in studies of
circadian variation of migraine attack onset.
5. Limitations
Only published articles (until August 2018) from English-
language journals were searched; data from conference
abstracts or publications written in other languages were not
included. We did not have information on unpublished data
or on any form of publication bias.
We identified other studies that investigated a similar
subject, but did not employ a full 24-hour long time range
regarding the distribution of migraine attacks; therefore such
articles were left out from the current review.
6. Conclusion
Most studies on circadian variation of migraine attack onset
show an early morning or late night peak but there is a
significant amount of studies revealing contrasting data. This
contradiction could at least in part result from method-
ological differences between studies. Heterogeneity among
migraineurs and migraine attacks is another option possibly
contributing to discrepancy, as different migraine subtypes
may develop via different pathways in their pathomech-
anism, and migraine attacks can be provoked by several
factors. Future studies should focus on producing more
generalizable data with the use of large enough samples
(even among migraine subtypes) and controlling for all the
relevant determinants, including age, gender, comorbidities,
and environmental factors, especially stress. For the present,
we only have theories that need to be tested in future studies
as the exact mechanism explaining the circadian variation of
migraine attack onset is not fully understood yet. A better
understanding of this complex mechanism could contribute
to the development of migraine therapy.
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